Anas, Bay-nor A.

HRN: 14-82-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2026
CEFTAZIDIME 1GM (VIAL)
04/29/2026
05/07/2026
IV
2g
Q8H
CAP MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: